Cargando…
Urinary Biomarkers at Early ADPKD Disease Stage
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by a decline in renal function at late disease stage when the majority of functional renal parenchyma is replaced by cystic tissue. Thus, kidney function, assessed by estimated glomerular filtration rate (eGFR) does no...
Autores principales: | Petzold, Katja, Poster, Diane, Krauer, Fabienne, Spanaus, Katharina, Andreisek, Gustav, Nguyen-Kim, Thi Dan Linh, Pavik, Ivana, Ho, Thien Anh, Serra, Andreas L., Rotar, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395321/ https://www.ncbi.nlm.nih.gov/pubmed/25875363 http://dx.doi.org/10.1371/journal.pone.0123555 |
Ejemplares similares
-
Low-Dose Oral Sirolimus and the Risk of Menstrual-Cycle Disturbances and Ovarian Cysts: Analysis of the Randomized Controlled SUISSE ADPKD Trial
por: Braun, Matthias, et al.
Publicado: (2012) -
Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance
por: Krauer, Fabienne, et al.
Publicado: (2012) -
Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study
por: Serra, Andreas L, et al.
Publicado: (2007) -
Night blindness in a haemodialysed ADPKD patient receiving octreotide
por: Ho, Thien Anh, et al.
Publicado: (2012) -
Defining Cardiac Dysfunction in ADPKD
por: Kuo, Ivana Y.
Publicado: (2023)